302430 — Innometry Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩111bn
- KR₩97bn
- KR₩84bn
- 48
- 58
- 43
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 26,824 | 23,882 | 7,064 | 21,217 | 14,774 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 22,668 | 12,896 | 25,350 | 33,364 | 39,596 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 50,974 | 37,943 | 34,536 | 60,001 | 64,758 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8,432 | 14,061 | 13,821 | 15,751 | 16,372 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 61,620 | 55,478 | 67,593 | 80,018 | 86,515 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,604 | 7,776 | 13,528 | 23,853 | 22,310 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9,280 | 8,383 | 13,911 | 24,266 | 22,437 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 52,341 | 47,095 | 53,682 | 55,753 | 64,078 |
Total Liabilities & Shareholders' Equity | 61,620 | 55,478 | 67,593 | 80,018 | 86,515 |
Total Common Shares Outstanding |